Search companies or stocks...
PABPatrys Limited
At close · 02 Sept 2026, 06:10 am
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Buy
Based on 0 analysts giving stock ratings to PAB in the past 3 months.
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab…
Current stock price of Patrys Limited (PAB) stock is $0.030. The stock price is -3.23% lower in the session. The intraday range can be seen from this page. Volume of Patrys Limited (PAB) stock is 582.12K.
Last updated at 02 Sept 2026, 06:10 am.
The stock price of Patrys Limited (PAB) can change with earnings, company news, and overall market sentiment. Patrys Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Patrys Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PAB on this page is -2.53. EPS on this page is -0.01. Compare those figures with peers and growth expectations before deciding if the current Patrys Limited price is justified.
Historical performance for Patrys Limited (PAB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PAB reacted to past earnings and market events.
Buying Patrys Limited (PAB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
